Cardiovascular disease and cancer are responsible for the majority of deaths in the Western world. These two entities share common risk factors and their intersection will be more and more frequent in future due to general population aging and long-term cancer control. Clinical presentation, management and outcome of acute coronary syndromes (ACS) in cancer patients could differ from noncancer ones. Cancer patients were frequently excluded from clinical trials and so the paucity of data further complicates the scenario. The management of ACS in cancer patients represents a unique setting in which the risk/benefit ratio of invasive treatment should be carefully evaluated. This review focused on the available evidence of all aspects of ACS in cancer patients providing a guide to a multidisciplinary approach.

心血管疾病和癌症是西方世界大多数死亡的原因。这两个实体具有共同的风险因素，并且由于总体人口老龄化和长期癌症控制，未来它们的交集将越来越频繁。癌症患者的急性冠状动脉综合征（ACS）的临床表现，管理和结果可能与非癌症患者不同。癌症患者经常被排除在临床试验之外，因此数据匮乏进一步加剧了这一情况。癌症患者中ACS的管理代表了一种独特的环境，在这种环境中，应仔细评估侵入性治疗的风险/收益比。这篇综述集中在癌症患者中ACS各个方面的可用证据，为多学科方法提供了指南。